chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She got her vaccine, and in the middle of the night she started feeling feverish.  On Saturday morning she had 101 fever, chills, aches and pains, joint pains that were very very bad, and a very very bad migraine headache.  This continued all day Sunday.  Monday she called her PCP, her fever was then gone.  The joint pains started feeling better, the headache started feeling better.  Then she started with very very bad nausea, diarrhea and head congestion like a cold.  she has been feeling the nausea, diarrhea and head congestion since Monday.  She went to UC on Monday as her PCP suggested that she do that, and was told to get a PCR test.  This came back negative.  She did 3 rapid tests that were all negative. The UC feels it is due to the vaccine, and she is still sick, and she believes it is from the vaccine as well as she woke up in the middle of the night being sick.  They told her to take Tylenol if she had anymore fever or aches or pains, but that was gone by the time she went to the UC on Monday.   She does have migraines and was taking her migraine medicine, and she is so upset as she got the vaccine to make yourself not get sick and she is now sick, and she is not getting anymore in the future.
I have been congestive, headache, sore throat, fatigue, and a cough at night. No fever. Went to a clinic, they did a COVID-19 test. It came back negative.
Nausea, dizziness and fainted for some few minutes. Paramedics were called, patient did not need any treatment and was able to go home.. Mom was counseled on signs and symptoms to watch out and if needed to seek medical care
This spontaneous report was received from a register nurse, refers to an unspecified number of patients, of unknown age and gender. The patient's medical history and concurrent conditions were not reported. The register nurse informed that on an unknown date, the patients were vaccinated with improperly stored doses of M-M-R II, (lot # L003859, expiration date: 05-FEB-2017; (strength, dosage and route were not reported). Concomitant therapy was not reported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Pt received the Pfizer-Biontech COVID19 Vaccine, Lot #EH9899 around 1830 today (12/22). A few minutes after the vaccine was administered in the left arm, the patient started having itching on her left shoulder that spread up to her neck. This was followed up by a warm feeling and mild blotching on the neck and face, more so on the left side of her body/face. When the patient brought this to staff attention, we began very close monitoring and started taking vitals regularly. Blood pressure ranging from 141/91 to 139/86, HR ranging from 120-86 bpm. . Around 1905 the patient was given Benadryl 25 mg tabs- 2 tablets by mouth one time only. Around 1908 the patient said her L ear started to itch also. We took vitals multiple times and the blood pressure and heart rate had decreased. Around 1935 the patient said she was feeling better, the mild blotching on the L side of her face and neck had almost completely resolved. The patient stated she felt much better and felt that she can could drive home safely. The patient spent a total time of one hour being monitored.    Of note: the patient admitted that she has white coat hypertension and today it was probably even worse. She said she had a lot of caffeine today and that could have also led to her being tachycardiac.
Pt recvd Hep B vax on 18JUN91 & on 26JUN91 pt devel numbness & tingling down rt arm to fingers; dec bicep & grip strength was noted; 2 days later devel swelling of lips w/tingling in lips & neck; 7 to 10 days later pt recovered;
My heart rate, I was like in AFib; very high fever of 103; dizzy, light headed; arms sore; exhausted like an extreme fatigue; palpitations; This is a spontaneous report from a contactable consumer (patient).  A 38-year-old female patient received the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EH9899), via an unspecified route of administration on 30Dec2020 at 38-years-old at a single dose for COVID-19 immunization.  Medical history included blood clotting disorder from an unknown date and unknown if ongoing.  The patient experienced the following events and outcomes: my heart rate, I was like in AFib (medically significant) on 31Dec2020 with outcome of recovering, very high fever of 103 (non-serious) on 31Dec2020 with outcome of unknown, dizzy, light headed (non-serious) on 31Dec2020 with outcome of unknown, arms sore (non-serious) on 31Dec2020 with outcome of unknown, exhausted like an extreme fatigue (non-serious) on 31Dec2020 with outcome of not recovered, palpitations (non-serious) on 31Dec2020 with outcome of not recovered.  The clinical course was reported as follows: The patient stated, "the day after the shot I got a very high fever of 103. I was dizzy, lightheaded. My heart rate I was like in AFib, it was going from 60s to 50s all over the place. And this was the next day after the vaccination. That evening nothing my arms was just sore. But the next day all of these side effects just started in and even still today I just feel so exhausted like an extreme fatigue and I am still getting like palpitations." The patient stated, "So I went to urgent care and they check my vitals and stuff and when they wanted me to send me to the hospital. But I told them I will get a ride and I go by myself just because I didn't want, capable of an ambulance ride and I ended up just going home because I couldn't get a hold up anybody. So, I came home and took my blood thinner medication because I do have blood clotting disorder."  In regard to the outcomes of the events, the patient stated, "I am not experiencing all of them still definitely my heart is much better. I am still getting palpitations but nothing near how it was that first day. I am experiencing extreme fatigue."
Since getting the Td vaccination on 7/24/03, he breaks out every 4-7 days.  Has atopic eczema.  Has had skin biopsy.  Is losing his vision.  Mother of child reports that she has spoken with Merck and CDC, and that they requested this VAERS report be filed on both vaccines.  Moved on 7/25/03. The medical records received on 1/20/04 states photophobia, flushed face, and keratopathy. Medical record states vasodilatation, photophobia.
One week after 1st shot arm was sore and developed a red rash around the injection area  was better within 2 days After 2nd shot developed fever up to 101.3. Bad headache, body aches, chills, arm sore  sore under the arms and fatigued.  This started about 12 hours after shot. Then about 36 hours after shot red rash appeared at site of second shot.  It is still red and sore 48 hours after shot.
Patient presented with fever of 104, cough, shortness of breath, O2 of 90 and body aches for 10 days. She went to ED on day 8 and received fluids and a steroid.
The day after vaccination the patient was irritable with myoclonic jerks. The patient was treated with Tylenol and Phenobarbitol.
Pt dx with intussusception on 2/27/11 successfully reduced, no concerns at this time. Had rec'd ROTATEQ on 2/11/11.
01/29/2021 I had scorpion feeling bites (pain) left upper shoulder and bite, had 3 to 5 lesions that were diagnosed as shingles. occasionally still have some residual nerve pain from the shingles.
As recipient was receiving injection of GARDASIL, she felt pain and then just started to mumble and repeat her words. She turned pale and slumped forward. She did not lose consciousness. Got nauseous and pale about 5 minutes later and a little lightheaded. Put her head between her legs and she felt better after about 5-10 minutes. GARDASIL was 3rd injection.
This spontaneous report as received from a pharmacist refers to an unspecified number of patients whose age and gender were not reported. On an unknown date the patients were vaccinated with a dose of improperly stored ZOSTAVAX injection via parenteral route, lot # M037656, expiry date: 29-NOV-2017 for prophylaxis with a properly stored sterile water diluent whose lot number and expiration date were not reported. The ZOSTAVAX received by the patients were reported to be stored at temperature of -9 degree centigrade to 8 degree centigrade for a duration of three months. It was reported that there was no previous temperature excursion. The report was received because of data logger. No adverse effects were reported for the patients.
Pain all over her body; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain all over her body) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 vaccination.     The patient's past medical history included Knee injury (15 years ago).    On 21-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Pain all over her body). At the time of the report, PAIN (Pain all over her body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information was not reported. Treatment information was not reported.  Patient stated that she injured her right kneel 15 years ago but now both of her knees ache really bad. Patient used Tylenol to alleviate the pain, but the relief is not long lasting. patient plans to see her healthcare provider about her knees. Her knees still ache.   This case was linked to MOD-2021-304929 (Patient Link).
Information has been received from a physician concerning a 65-year-old female who on 12-FEB-2006 was vaccinated with a 0.65 ml dose of Zostavax. On 19-FEB-2007 the patient developed a breakthrough rash on her face. Unspecified medical attention was sought. There was no additional information. There was no product quality complaint.  Additional information has been requested. 06/22/07 This is in follow-up to report(s) previously submitted on 3/14/2007. Information has been received from a physician concerning a 73 year old female with hypertension, chronic renal failure and hyperthyroidism who on 13 DEC 2007 at 11:15 was vaccinated intramuscularly with a first dose of ZOSTAVAX (Oka/Merck) (lot # 652925/0621F). There was no acute illness at the time of vaccination. Concomitant therapy included "doxazocin", EVISTA, ALLOPURINOL MSD, aspirin, TOPROL XL tablets and LEVOXYL. On 19-FEB-2007 the patient developed a zoster like rash on the right side of the forehead and bilateral intraorbital blisters. Unspecified medical attention was sought. A viral culture was obtained from the vesicles, on an unspecified date. The findings remain pending. There was no product quality complaint. At the time of reporting the final outcome was uknown.   Information has been received from a physician concerning a 73 year old female (weight 1318) with hypertension, chronic renal failure and hypothyroidism who on 13-FEB-2007 at 11:15 was vaccinated intramuscularly with a first dose of ZOSTAVAX (Merck) (lot # 652925/0621F). IM in the left arm. There was no acute illness at the time of vaccination. Concomitant therapy included "doxarocin", EVISTA, allupurinol (manufacturer unknown), aspirin, TOPROL XL tablets and LEVOXYL.  On 17-FEB-2007, the patient developed a zoster like rash on the right side of face and forehead, and bilateral intraorbital blisters. Unspecified medical attention was sought. On an unspecified date, a viral culture was obtained from the vesicles which were negative for varicella virus. There was no product quality complaint. On 13-MAR-2007, the patient recovered from the events.   Additional information is not expected.
Reported from mother: Pt was admitted to hospital 2-18-09 due to fever 104.6. Stated blood culture done in ER was (+) for bacterial infection. Repeat blood cultures on Friday were negative. Stool cultures done were negative. Pt was released home 2-21-09 in a.m. with Rx AZITHROMAX. Spoke with mother 2-24-09 states pt doing well with no fever and has been Tx with antbx.  2/25/09 MR received for DOS 2/19-21/2009 with DX: Fever w/o source.  Leukocytosis.  Pt presented with 2 day hx of fever. Received vax today and fever up to 104.6. PE (+) for cough and rhinorrhea, mild tachycardia. Admitted for observation and tx with abx.
PATIENT STATES THAT THE DAY AFTER RECEIVING THE VACCINE HIS HEART RATE WAS ELEVATED CONSISTENTLY.
Patient reports that at the time of injection she felt numbness in her left thumb and tingling in her arm.   It quickly resolved but over the past few hours has been on and off numb for the past few hours.  She says at one point her pinky felt numb, then the side of her arm but strength is normal.  Her arm is also sore.
Information has been received from a healthcare worker referring to unspecified patients of unknown age and gender. On unspecified dates, the patients received improperly stored doses of ROTATEQ (oral, strength, lot #, expiration dates and dose were unknown) (incorrect product storage). No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry) in a 54-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported No treatment drugs were reported    This case was linked to MOD-2021-395985 (Patient Link).
Information has been received from a registered nurse concerning a female patient over the age of 65 who on approximately 05-FEB-2007 was vaccinated SC with a dose of Zostavax. Five days after vaccination, on approximately 10-FEB-2007, the patient developed a rash on her chest described as itchy blisters. The rash covered her chest above her breast-line and spread from the right side to the left side of her body. Unspecified medical attention was sought. The nurse gave the patient hydrocortisone cream for the rash. A product quality complaint was not involved. Additional information has been requested.
Large area of erythema (18cm x 9cm) and pain in area of vaccine site (upper arm). Treated with ice, NSAIDS, antihistamine.
This is an instance of breakthrough COVID-19 disease after which death occurred.   The individual was vaccinated with the Pfizer product on 02/05/2021 and 03/17/2021. They became symptomatic on 08/31/2021 and first tested positive for COVID-19 on 09/01/2021. They presented to emergency department on 09/01/2021. They were admitted to hospital on 09/01/2021 and discharged 09/02/2021. They presented to emergency department again on 09/08/2021 but were not admitted to hospital at this time. They presented to emergency department again on 09/15/2021 after blood culture results from a sample collected 09/08/2021 were positive for staph auricularis. They were admitted to hospital this time, on 09/15/2021. A second COVID-19 test was positive on 09/16/2021. They were discharged 09/21/2021. They were then re-admitted 09/21/2021 and found to be having multiple complications and issues including: scrotoal gangrene, respiratory failure, hypoxia, and mild pulmonary edema. The individual code blue'd  while in the hospital on 09/26/2021 and per the wishes of the next of kin, CPR was discontinued. It was determined the individual had suffered a cardiac arrest, either due to a fatal arrhythmia or cardiogenic shock. Date of death was 09/26/2021.
Patient came in for flu and RSV vaccs and was administered flu and shingles (in error). No known adverse reaction occurred.
On 10/04/2022, I woke up with a sore throat. It later progressed to a headache. I took Ibuprofen for that. On 10/05/2022, I was feeling similarly with a sore throat and headache but also had a lot of nasal drainage and sinus pressure, along with a cough. I thought it was a cold. Things progressed until Sunday when I couldn't take it anymore. I had tooth pain and drainage from eyes, ears, and nose. I went to see the doctor on 10/10/2022. She diagnosed me with a sinus infection and prescribed an antibiotic. After taking the antibiotic, within 24 hours I saw improvement in my symptoms and by 48 hours, I was almost back to normal.
No adverse event.; A patient was administered an improperly stored ROTATEQ; This spontaneous report was received from a medical assistant, referring to patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history, concomitant medications and previous drugs reactions or allergies were not provided.  On 01-NOV-2019, the patient was vaccinated with an improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) orally, as prophylaxis (concentration, number of administered dose and vaccination scheme frequency were not reported; lot number 1660935 has been verified to be a valid lot number, expiration date 06-OCT-2020). No adverse effects were reported for the patient.  According to the reporter, the temperature excursion was 51.28 degrees Fahrenheit, also reported as total time with the highest temperature above 47 degrees Fahrenheit / 9 degrees Celsius for a time frame of 2 hours and 16 minutes (product storage error), without any previous temperature excursion; no digital data logger was involved.
Patient had her COVID injection on 12/29 and she developed numbness/tingling later that night in her arms, around 9pm (had vaccine at 2pm). She saw provider on 12/31/20 and was given gabapentin to try. She has been taking it twice daily and it helps a little. She said that the numbness seems to be getting less. She said it was all the way from the shoulder to the hands/fingers, now it's just in her hands and fingers. (Both sides, not just injection site). Circulation is good.
This case was reported by a healthcare professional and described the occurrence of arm swollen in a 6-year-old male subject who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine (Infanrix, GlaxoSmithKline) plus a separate injection of inactivated poliomyelitis virus vaccine (IPOL) for prophylaxis. On 03 October 2006 the subject received 5th dose of Infanrix (lot AC14A007BA) in an unspecified arm. The expiration date for this lot of Infanrix is 11 September 2006. On 03 October 2006 the subject also received 4th dose of IPOL in the opposite arm. On 03 October 2006 and on or before 05 October 2006, the father of the subject reported to the healthcare profession that the subject's arm was red and swollen. The healthcare professional reported that she did "not recall if the redness and swelling was in the arm in which Infanrix was given." The outcome of redness and swelling was not reported.
she has tested positive for the virus twice. And have received both vaccine doses.; she has tested positive for the virus twice. And have received both vaccine doses.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "COVID-19" (unspecified if ongoing), notes: positive for covid 19 for the second time. The patient's concomitant medications were not reported. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant), outcome "unknown" and all described as "she has tested positive for the virus twice. And have received both vaccine doses.". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: positive; positive. Clinical course reported as my girlfriend is positive for COVID 19 for the second time, she has tested positive for the virus twice and have received both vaccine doses.  The lot number for bnt162b2 was not provided and will be requested during follow up.
01272021 1700 left arm ache 01282021 0600 severe ache to left arm 01282021 1200 additional body aches 01282021 1700 aches continue to worsen, headache, trembling, chills, skin "pain", oral burning, temp 100.8.    Alternated ibuprofen and tylenol throughout.    01292021 0500 All symptoms resolved, left arm pain, mild.
On day of vaccines, quarter-sized red area on left thigh. By evening at 20:30, had 5"-6" diameter round red area with rash surrounding and itchy at site of left thigh (DPTA or MMR). On 7/10/01, still with 5"-6" area faded rash at left thigh. (Per mother's statement".
experiencing difficulty with the vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (experiencing difficulty with the vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (experiencing difficulty with the vaccine). At the time of the report, VACCINATION COMPLICATION (experiencing difficulty with the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported  No treatment drugs were reported   This case was linked to MODERNATX, INC.-MOD-2021-101616 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: FU attached is for the patient, therefore no information has been taken as the case is of patient's neighbor. On 21-Jul-2021: Follow up received contains no new information (NNI); Sender's Comments:  MODERNATX, INC.-MOD-2021-101616:Patient's case
This is a spontaneous report from a contactable pharmacist communicated to a Pfizer sales representative. A female patient (in her 60s) of an unspecified ethnicity, received PREVNAR 13, via an unspecified route of administration on an unspecified date and PNEUMOVAX 23, via an unspecified route of administration on an unspecified date both as single doses for immunization.  The patient's medical history and concomitant medications were not reported.  The patient experienced arm infection in the vaccinated arm and patient got PREVNAR 13 and PNEUMOVAX 23 on the same day on an unspecified date.  The outcome of experienced arm infection in the vaccinated arm and patient got PREVNAR 13 and PNEUMOVAX 23 on the same day was unknown.
When I get the flu shot I have flu symptoms for 3 months, so I stopped getting that a couple years ago. So after the 2nd shot of moderna, I have had covid symptoms still as of today included sneezing, runny nose, congestion, upper respiratory symptoms, wheezing, coughing, and phlegm. I have been on 6 day dose of PREDNISONE twice, ALBUTEROL inhaler, and SINGULAR. This has totally triggered some sort of asthma - allergy related symptoms. I am so over feeling like this.